In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Analysis of myocardial fibrosis using cardiac magnetic resonance T1 imaging and late gadolinium enhancement: Association with ventricular tachycardia in hypertrophic cardiomyopathy

Session Poster Session 4

Speaker Akiko Sakai

Congress : ESC Congress 2018

  • Topic : imaging
  • Sub-topic : T1 and T2 Mapping, T2*
  • Session type : Poster Session
  • FP Number : P3701

Authors : T Abe (Tokyo,JP), A Sakai (Tokyo,JP), E Watanabe (Tokyo,JP), M Nagao (Tokyo,JP), S Sakai (Tokyo,JP), N Hagiwara (Tokyo,JP)

Authors:
T. Abe1 , A. Sakai1 , E. Watanabe1 , M. Nagao2 , S. Sakai2 , N. Hagiwara1 , 1Tokyo Women's Medical University, cardiology - Tokyo - Japan , 2Tokyo Women's Medical University, Department of Diagnostic Imaging & Nuclear Medicine - Tokyo - Japan ,

Citation:
European Heart Journal ( 2018 ) 39 ( Supplement ), 775

Introduction: Myocardial fibrosis is a risk factor for ventricular tachycardia (VT) and the worsening of heart failure in patients with hypertrophic cardiomyopathy (HCM). The present study investigates whether myocardial fibrosis using cardiac magnetic resonance T1 imaging and late gadolinium enhancement (LGE) could be a surrogate marker for VT in patients with HCM.

Methods: A total of 57 patients with HCM (mean age 58±15 years, 84% men)underwent LGE and saturation recovery T1 measurements with 3 Tesla scanner to quantify myocardial fibrosis. The extracellular volume (Septal-ECV, %) for mid-left ventricular septum was calculated by T1 values pre- and post-LGE. LGE volume (cm3) for the whole left ventricle was measured using the cutoff of more than 6 standard deviation of normal myocardial intensity. Comparison of septal-ECV and LGE volume between patients with and without VT was analyzed.

Results: VT was observed in 22 (38%) of 57 patients. Septal-ECV and LGE volume was significantly greater for patients with VT than those without (33±17% vs. 25±11%, 22±11cm3 vs. 14±9cm3, p<0.05). The optimal cutoffs of septal-ECV and LGE volume can predict patient with VT with an area under the curve of 0.63 and 0.7.

Conclusion: Septal-LGE and LGE volume can be used as a surrogate marker for VT in HCM. LGE volume is more precise in the prediction of VT than septal-ECV.



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are